204 related articles for article (PubMed ID: 34789471)
1. High Prediagnosis Inflammation-Related Risk Score Associated with Decreased Ovarian Cancer Survival.
Brieger KK; Phung MT; Mukherjee B; Bakulski KM; Anton-Culver H; Bandera EV; Bowtell DDL; Cramer DW; DeFazio A; Doherty JA; Fereday S; Fortner RT; Gentry-Maharaj A; Goode EL; Goodman MT; Harris HR; Matsuo K; Menon U; Modugno F; Moysich KB; Qin B; Ramus SJ; Risch HA; Rossing MA; Schildkraut JM; Trabert B; Vierkant RA; Winham SJ; Wentzensen N; Wu AH; Ziogas A; Khoja L; Cho KR; McLean K; Richardson J; Grout B; Chase A; Deurloo CM; Odunsi K; Nelson BH; Brenton JD; Terry KL; Pharoah PDP; Berchuck A; Hanley GE; Webb PM; Pike MC; Pearce CL;
Cancer Epidemiol Biomarkers Prev; 2022 Feb; 31(2):443-452. PubMed ID: 34789471
[TBL] [Abstract][Full Text] [Related]
2. Prediagnosis and postdiagnosis smoking and survival following diagnosis with ovarian cancer.
Wang T; Townsend MK; Simmons V; Terry KL; Matulonis UA; Tworoger SS
Int J Cancer; 2020 Aug; 147(3):736-746. PubMed ID: 31693173
[TBL] [Abstract][Full Text] [Related]
3. A healthy lifestyle and survival among women with ovarian cancer.
Hansen JM; Nagle CM; Ibiebele TI; Grant PT; Obermair A; Friedlander ML; DeFazio A; Webb PM;
Int J Cancer; 2020 Dec; 147(12):3361-3369. PubMed ID: 32542708
[TBL] [Abstract][Full Text] [Related]
4. Joint exposure to smoking, excessive weight, and physical inactivity and survival of ovarian cancer patients, evidence from the Ovarian Cancer Association Consortium.
Minlikeeva AN; Cannioto R; Jensen A; Kjaer SK; Jordan SJ; Diergaarde B; Szender JB; Odunsi K; Almohanna H; Mayor P; Starbuck K; Zsiros E; Bandera EV; Cramer DW; Doherty JA; DeFazio A; ; Edwards R; Goode EL; Goodman MT; Høgdall E; Matsuo K; Mizuno M; Nagle CM; Ness RB; Paddock LE; Pearce CL; Risch HA; Rossing MA; Terry KL; Wu AH; Modugno F; Webb PM; Moysich KB;
Cancer Causes Control; 2019 May; 30(5):537-547. PubMed ID: 30905014
[TBL] [Abstract][Full Text] [Related]
5. Association of inflammation-related exposures and ovarian cancer survival in a multi-site cohort study of Black women.
Johnson CE; Alberg AJ; Bandera EV; Peres LC; Akonde M; Collin LJ; Cote ML; Hastert TA; Hébert JR; Peters ES; Qin B; Terry P; Schwartz AG; Bondy M; Epstein MP; Mandle HB; Marks JR; Lawson AB; Schildkraut JM
Br J Cancer; 2023 Oct; 129(7):1119-1125. PubMed ID: 37537254
[TBL] [Abstract][Full Text] [Related]
6. Prediagnosis food patterns are associated with length of survival from epithelial ovarian cancer.
Dolecek TA; McCarthy BJ; Joslin CE; Peterson CE; Kim S; Freels SA; Davis FG
J Am Diet Assoc; 2010 Mar; 110(3):369-82. PubMed ID: 20184987
[TBL] [Abstract][Full Text] [Related]
7. Non-aspirin NSAID use and ovarian cancer mortality.
Verdoodt F; Dehlendorff C; Friis S; Kjaer SK
Gynecol Oncol; 2018 Aug; 150(2):331-337. PubMed ID: 29960709
[TBL] [Abstract][Full Text] [Related]
8. Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer Association Consortium.
Cannioto RA; LaMonte MJ; Kelemen LE; Risch HA; Eng KH; Minlikeeva AN; Hong CC; Szender JB; Sucheston-Campbell L; Joseph JM; Berchuck A; Chang-Claude J; Cramer DW; DeFazio A; Diergaarde B; Dörk T; Doherty JA; Edwards RP; Fridley BL; Friel G; Goode EL; Goodman MT; Hillemanns P; Hogdall E; Hosono S; Kelley JL; Kjaer SK; Klapdor R; Matsuo K; Odunsi K; Nagle CM; Olsen CM; Paddock LE; Pearce CL; Pike MC; Rossing MA; Schmalfeldt B; Segal BH; Szamreta EA; Thompson PJ; Tseng CC; Vierkant R; Schildkraut JM; Wentzensen N; Wicklund KG; Winham SJ; Wu AH; Modugno F; Ness RB; Jensen A; Webb PM; Terry K; Bandera EV; Moysich KB
Br J Cancer; 2016 Jun; 115(1):95-101. PubMed ID: 27299959
[TBL] [Abstract][Full Text] [Related]
9. Pre-diagnosis and post-diagnosis use of common analgesics and ovarian cancer prognosis (NHS/NHSII): a cohort study.
Merritt MA; Rice MS; Barnard ME; Hankinson SE; Matulonis UA; Poole EM; Tworoger SS
Lancet Oncol; 2018 Aug; 19(8):1107-1116. PubMed ID: 30029888
[TBL] [Abstract][Full Text] [Related]
10. Prediagnostic Proinflammatory Dietary Potential Is Associated with All-Cause Mortality among African-American Women with High-Grade Serous Ovarian Carcinoma.
Peres LC; Hebert JR; Qin B; Guertin KA; Bandera EV; Shivappa N; Camacho TF; Chyn D; Alberg AJ; Barnholtz-Sloan JS; Bondy ML; Cote ML; Funkhouser E; Moorman PG; Peters ES; Schwartz AG; Terry PD; Schildkraut JM
J Nutr; 2019 Sep; 149(9):1606-1616. PubMed ID: 31152675
[TBL] [Abstract][Full Text] [Related]
11. Ambient air pollution and ovarian cancer survival in California.
Villanueva C; Chang J; Ziogas A; Bristow RE; Vieira VM
Gynecol Oncol; 2021 Oct; 163(1):155-161. PubMed ID: 34330535
[TBL] [Abstract][Full Text] [Related]
12. Diet quality and survival after ovarian cancer: results from the Women's Health Initiative.
Thomson CA; E Crane T; Wertheim BC; Neuhouser ML; Li W; Snetselaar LG; Basen-Engquist KM; Zhou Y; Irwin ML
J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25335480
[TBL] [Abstract][Full Text] [Related]
13. Pre-diagnosis body mass index, physical activity and ovarian cancer mortality.
Zamorano AS; Hagemann AR; Morrison L; Lee JA; Liao LM; Brinton LA; Park Y; Toriola AT
Gynecol Oncol; 2019 Oct; 155(1):105-111. PubMed ID: 31383570
[TBL] [Abstract][Full Text] [Related]
14. Association of Prediagnosis Obesity and Postdiagnosis Aspirin With Survival From Stage IV Colorectal Cancer.
Davis JS; Chavez JC; Kok M; San Miguel Y; Lee HY; Henderson H; Overman MJ; Morris V; Kee B; Fogelman D; Advani SM; Johnson B; Parseghian C; Shen JP; Dasari A; Shaw KR; Vilar E; Raghav KP; Shureiqi I; Wolff RA; Meric-Bernstam F; Maru D; Menter DG; Kopetz S; Chang S
JAMA Netw Open; 2022 Oct; 5(10):e2236357. PubMed ID: 36239938
[TBL] [Abstract][Full Text] [Related]
15. Cigarette smoking is associated with adverse survival among women with ovarian cancer: Results from a pooled analysis of 19 studies.
Praestegaard C; Jensen A; Jensen SM; Nielsen TS; Webb PM; Nagle CM; DeFazio A; ; Høgdall E; Rossing MA; Doherty JA; Wicklund KG; Goodman MT; Modugno F; Moysich K; Ness RB; Edwards R; Matsuo K; Hosono S; Goode EL; Winham SJ; Fridley BL; Cramer DW; Terry KL; Schildkraut JM; Berchuck A; Bandera EV; Paddock LE; Massuger LF; Wentzensen N; Pharoah P; Song H; Whittemore A; McGuire V; Sieh W; Rothstein J; Anton-Culver H; Ziogas A; Menon U; Gayther SA; Ramus SJ; Gentry-Maharaj A; Wu AH; Pearce CL; Pike M; Lee AW; Sutphen R; Chang-Claude J; Risch HA; Kjaer SK;
Int J Cancer; 2017 Jun; 140(11):2422-2435. PubMed ID: 28063166
[TBL] [Abstract][Full Text] [Related]
16. Appraising the role of previously reported risk factors in epithelial ovarian cancer risk: A Mendelian randomization analysis.
Yarmolinsky J; Relton CL; Lophatananon A; Muir K; Menon U; Gentry-Maharaj A; Walther A; Zheng J; Fasching P; Zheng W; Yin Ling W; Park SK; Kim BG; Choi JY; Park B; Davey Smith G; Martin RM; Lewis SJ
PLoS Med; 2019 Aug; 16(8):e1002893. PubMed ID: 31390370
[TBL] [Abstract][Full Text] [Related]
17. Pre- and Post-Diagnosis Diet Quality and Ovarian Cancer Survival.
Al Ramadhani RM; Nagle CM; Ibiebele TI; Grant P; Friedlander M; DeFazio A; Webb PM;
Cancer Epidemiol Biomarkers Prev; 2021 Jan; 30(1):229-232. PubMed ID: 33144284
[TBL] [Abstract][Full Text] [Related]
18. Aspirin use and ovarian cancer mortality in a Danish nationwide cohort study.
Verdoodt F; Kjaer SK; Dehlendorff C; Friis S
Br J Cancer; 2018 Feb; 118(4):611-615. PubMed ID: 29315293
[TBL] [Abstract][Full Text] [Related]
19. Common analgesics and ovarian cancer survival: the Ovarian cancer Prognosis And Lifestyle (OPAL) Study.
Majidi A; Na R; Jordan SJ; DeFazio A; Obermair A; Friedlander M; Grant P; Webb PM
J Natl Cancer Inst; 2023 May; 115(5):570-577. PubMed ID: 36744914
[TBL] [Abstract][Full Text] [Related]
20. Statin use and survival following a diagnosis of ovarian cancer: A prospective observational study.
Majidi A; Na R; Jordan SJ; De Fazio A; Webb PM;
Int J Cancer; 2021 Apr; 148(7):1608-1615. PubMed ID: 33034053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
